Oregon's Hard-Stop Policy Tied to Drop in Elective Early Delivery

Share this content:
Oregon's Hard-Stop Policy Tied to Drop in Elective Early Delivery
Oregon's Hard-Stop Policy Tied to Drop in Elective Early Delivery

MONDAY, Nov. 14, 2016 (HealthDay News) -- Introduction of the hard-stop policy in Oregon was associated with a reduction in elective early-term deliveries, according to a study published in the December issue of Obstetrics & Gynecology.

Jonathan M. Snowden, Ph.D., from the Oregon Health & Science University in Portland, and colleagues conducted a population-based retrospective cohort study of Oregon births from 2008 to 2013. They examined the outcomes of induction of labor and cesarean section at 37 or 38 weeks of gestation without a documented indication on the birth certificate before and after the Oregon hard-stop policy (2008 to 2010 and 2012 to 2013, respectively).

The researchers observed a decrease in the rate of elective inductions before 39 weeks of gestation, from 4.0 percent in the pre-policy period to 2.5 percent during the post-policy period (P < 0.001); elective early-term cesarean deliveries also decreased (from 3.4 to 2.1 percent; P < 0.001). From pre- to post-policy, there was no change observed in neonatal intensive care unit admission, stillbirth, or assisted ventilation; chorioamnionitis increased from 1.2 to 2.2 percent (adjusted odds ratio, 1.94; P < 0.001).

"Oregon's statewide policy to limit elective early-term delivery was associated with a reduction in elective early-term deliveries, but no improvement in maternal or neonatal outcomes," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »